The emergence of a citation cartel. "Cell Transplantation is a medical journal published by the Cognizant Communication Corporation of Putnam Valley, New York. In recent years, its impact factor has been growing rapidly. In 2006, it was 3.482. In 2010, it had almost doubled to 6.204.
When you look at which journals cite Cell Transplantation, two journals stand out noticeably: the Medical Science Monitor, and The Scientific World Journal. According to the JCR, neither of these journals cited Cell Transplantation until 2010.
Then, in 2010, a review article was published in the Medical Science Monitor citing 490 articles, 445 of which were to papers published in Cell Transplantation. All 445 citations pointed to papers published in 2008 or 2009 — the citation window from which the journal’s 2010 impact factor was derived. Of the remaining 45 citations, 44 cited the Medical Science Monitor, again, to papers published in 2008 and 2009.
Three of the four authors of this paper sit on the editorial board of Cell Transplantation. Two are associate editors, one is the founding editor. The fourth is the CEO of a medical communications company."
(from
Scholarly Kitchen, via
Andrew Gelman.)
posted by escabeche
on May 15, 2012 -
26 comments
In March 2010, a pair of health inspectors responding to multiple tips paid a three-day visit to the factory headquarters of the
Poly Implant Prothese (PIP) company, a leading international maker of breast implants. On their second day, the inspectors found something odd: six discarded plastic containers of Silopren, a liquid silicone designed for industrial, not medical use, lined up along the outside wall of the production site. The lead inspector estimated they had contained nearly 9 tons of liquid silicone.
It now appears as if between 300,000 and 400,000 women throughout the world may have received potentially toxic, faulty breast implants containing ingredients never clinically tested on humans, manufactured and distributed by a company that knowingly deceived regulators, suppliers, distributors, medical professionals and ultimately, patients. Reuters photographer's Blog:
Operating on an implant scandal. (Last link NSFW, graphic images that contain nudity.) [more inside]
posted by zarq
on Feb 18, 2012 -
58 comments
"I'm banned," he says. "By whom?" I ask. "My landlord," he says. "And the Swedish Radiation Safety Authority." Jon Ronson on
DIY science.
posted by fearfulsymmetry
on Feb 4, 2012 -
33 comments
"I would point out to you that medical explanations are modern. That Americans today want medical explanations for things that in the 19th century would have been explained by hysteria, and in the 18th century would have been explained by religious conversion experiences in the context of the Great Awakening, when people were having these types of fits, and in the 17th century by witchcraft."
posted by empath
on Jan 30, 2012 -
54 comments
Day at Night was an interview series on the public television station of the City University of New York that aired from 1973-4. CUNY TV is in the process of digitizing and uploading the 130 episodes that were produced, with 46 done so far. The episodes are just under half an hour in length. Among the people interviewed by host James Day are author
Ray Bradbury, actress
Myrna Loy, medical researcher
Jonas Salk, singer
Cab Calloway, writer
Christopher Isherwood, nuclear scientist
Edward Teller, comedian
Victor Borge, tennis player
Billie Jean King, linguist and activist
Noam Chomsky, composer
Aaron Copland, actor
Vincent Price and boxer
Muhammad Ali.
posted by Kattullus
on Jan 16, 2012 -
6 comments
Falling STAR*D?: It is common practice for psychiatrists to switch depressive patients between different antidepressants if their current drug does not evince a symptomatic response. Despite clinical wisdom supporting this, little empirical, controlled evidence exists to direct “switching” protocols (e.g. if a patient with Z characteristics is on drug X, is it usually better to switch to drug A, B, or C? Will switching help at all?) in the psychopharmacological treatment of depression. The NIMH-funded
STAR*D (Sequenced Alternatives to Relieve Depression) study aimed to address these questions of treatment direction in a very large (n>4000), “real-world” sample using a
multi-phase treatment plan with different drugs (and cognitive therapy) at every step to maximize chances of eventual remission. Overall, the NIMH reported that about
67% of patients eventually achieved remission,
with few differences in effectiveness between different types of treatment at each step. However, researchers and commentators have
raised concerns regarding inconsistent reporting of outcomes, after-the-fact changes in
study design and analysis, and other issues that may have inflated, partially invalidated, or misrepresented widely reported treatment outcomes. These inequities may also have implications for the secondary moderator analyses (i.e. does trait A predict switching to X or Y is better?) that were a major reason for the study.
[more inside]
posted by Keter
on Jan 14, 2012 -
12 comments
How can we better understand the interplay of nature and nurture in determining our personalities, behavior, and vulnerability to disease? Perhaps we should be looking at
identical twins.
(National Geographic January 2012 cover story) [more inside]
posted by zarq
on Dec 19, 2011 -
89 comments
Biomedical Ephemera, or, a Frog for your Boils is "A blog for all biological and medical ephemera, from the age of Abraham through the era of medical quackery and cure-all nostrums. Sometimes featuring illustrations of diseases and conditions of the times, sometimes fascinating ephemeral medical equipment, and sometimes clippings and information about the theories themselves." The
archive page is also a useful starting point.
via Things Magazine.
posted by Rumple
on Aug 29, 2011 -
8 comments
Last week Johnson & Johnson
announced that it is lowering the maximum daily dose for single-ingredient Extra Strength Tylenol from 8 to 6 pills per day (from 4,000 to 3,000 mg).
[more inside]
posted by hat_eater
on Aug 4, 2011 -
54 comments
The Triumph of New-Age Medicine "Medicine has long decried acupuncture, homeopathy, and the like as dangerous nonsense that preys on the gullible. Again and again, carefully controlled studies have shown alternative medicine to work no better than a placebo. But now many doctors admit that alternative medicine often seems to do a better job of making patients well, and at a much lower cost, than mainstream care—and they’re trying to learn from it." [more inside]
posted by zarq
on Jun 15, 2011 -
278 comments
The Burns Archive is a collection of over 700,000 historical photographs that document
disturbing subject matter: obsolete medical practices and experiments, death, disease, disasters, crime, revolutions, riots and war. Newsweek posted a
select gallery this past October, as well as a
video interview and walk-through with curator and collector Dr. Stanley B. Burns, a New York opthalmologist.
(Via) (Content at links may be disturbing to some.) [more inside]
posted by zarq
on Apr 26, 2011 -
15 comments
"One day a little boy came up, he must have been about four and he saw me taking off my (prosthetic) legs and he started with the 'why' questions, you know, 'why haven't you got any legs', etc. And I said 'have you heard of The Little Mermaid?' and he said 'yes' and I said 'I'm a mermaid' and he got this look on his face and he said 'wow that's cool' and ran off to tell his dad.
I'll have to turn up to that beach again sometime with my tail - just in case he's there."
Weta Digital are the special effects team behind the costumes, weapons and creatures of the
Lord of the Rings movies,
Avatar and even
a sonic screwdriver prop that could be making an appearance on the next season of Doctor Who. In 2009, they
created a fully functional mermaid tail pro bono for Nadya Vessey,
an Auckland woman who is a double leg amputee. Video News Report:
1,
2.
posted by zarq
on Apr 5, 2011 -
37 comments
